Literature DB >> 365664

Immunofluorescence studies of apolipoprotein B in intestinal mucosa. Absence in abetalipoproteinemia.

R M Glickman, P H Green, R S Lees, S E Lux, A Kilgore.   

Abstract

During fat absorption, active synthesis of cholesterol, phospholipids, and specific apolipoproteins are required for chylomicron formation and secretion. In the inherited disease abetalipoproteinema, chylomicrons cannot be made in response to fat feeding, and they as well as low and very low density lipoproteins are completely absent from plasma. The genetic defect in the disease is presumed to be an inability to synthesize apolipoprotein B, the apoprotein common to all the above lipoprotein classes, but such a defect has not been directly demonstrated. With peroral intestinal biopsies and immunofluorescence and intracellular localization of apolipoprotein B within jejunal epithelial cells of five normal subjects and have shown that its content increases markedly after fat feeding. In two patients with abetalipoproteinemia no apolipoprotein B was seen by immunofluorescence techniques in the jejunal mucosa in the fasting state or after a fatty meal. Intestinal synthesis of apolipoprotein B appears not to occur in abetalipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 365664

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.

Authors:  P J Talmud; J K Lloyd; D P Muller; D R Collins; J Scott; S Humphries
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

2.  Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease.

Authors:  M E Bouma; I Beucler; L P Aggerbeck; R Infante; J Schmitz
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

Authors:  R P Dullaart; B Speelberg; H J Schuurman; R W Milne; L M Havekes; Y L Marcel; H J Geuze; M M Hulshof; D W Erkelens
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia.

Authors:  D R Collins; T J Knott; R J Pease; L M Powell; S C Wallis; S Robertson; C R Pullinger; R W Milne; Y L Marcel; S E Humphries
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

5.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  Apolipoprotein B detected in the plasma of a patient with homozygous hypobetalipoproteinaemia: implications for aetiology.

Authors:  G M Berger; G Brown; H E Henderson; F Bonnici
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

7.  Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia.

Authors:  L S Huang; P A Jänne; J de Graaf; M Cooper; R J Deckelbaum; H Kayden; J L Breslow; R J Decklebaum
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

8.  Human apolipoprotein A-IV. Intestinal origin and distribution in plasma.

Authors:  P H Green; R M Glickman; J W Riley; E Quinet
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

9.  Association of lipid accumulation in small intestinal mucosa with decreased serum triglyceride and cholesterol levels in AIDS.

Authors:  Y Benhamou; I Hilmarsdottir; I Desportes-Livage; C Hoang; A Datry; M Danis; M Gentilini; P Opolon
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.